Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast

Journal of Clinical Pathology

Volumn 56, Issue 12, 2003, Pages 919-923

  Teo, N B ^b   Shoker, B S ^b   Jarvis, C ^b   Sloane, J P ^b   Holcombe, C ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; PROTEIN ANTIBODY; THYMIDINE PHOSPHORYLASE; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST DUCT; CANCER RECURRENCE; CANCER SURGERY; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK; SCORING SYSTEM; STROMA; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS; THYMIDINE PHOSPHORYLASE;

EID: 0346780569     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.12.919     Document Type: Article

References (27)

1. Fryberg ER, Bland KI. Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer 1994;74:350-61.
2. Recht A, Danoff BS, Solin LJ, et al. Intraductal carcinoma of the breast: results of treatment with excision biopsy and irradiation. J Clin Oncol 1985;3:1339-43.
3. Silverstein MJ, Barth A, Poller DN, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31:1425-7.
4. Weidner N, Semple JP, Welch WR, et al. Tumour angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
5. Bosari S, Lee AKC, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
6. Horak E, Leek R, Klerk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
7. Weidner N, Folkman J, Pozza F, et al. Tumour angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
8. Karaiossifidi H, Kouri E, Arvaniti H, et al. Tumour angiogenesis in node-negative breast cancer: relationship with relapse free survival. Anticancer Res 1996;16(6C):4001-2.
9. Heimann R, Ferguson D, Powers C, et al. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst 1996;88:1764-9.
10. Guidi AJ, Fischer L, Harris JR, et al. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 1994;86:614-19.
11. Engels K, Fox SB, Whitehouse RM, et al. Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. J Pathol 1997;181:207-12.
12. Teo NB, Shoker BS, Jarvis C, et al. Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast. Eur J Cancer 2003;39:38-44.
13. Klagsburn M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991;53:217-39.
14. Engels K, Fox SB, Whitehouse RM, et al. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast. J Pathol 1997;182:414-20.
15. National Co-ordinating Group for Breast Screening Pathology. Pathology reporting in breasr cancer screening. Sheffield: NHSBSP Publications No 3, 1997.
16. The Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer 1997;80:1798-802.
17. Sales A, Ruiz A, Llombart-Bosch A. Comparative morphometric evaluation of microvessel density and nuclear area in ductal carcinoma in situ and hyperplastic ductal breast lesions. Breast 1999;8:21-5.
18. Valtola R, Slaven P, Heikkila P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999;154:1381-90.
19. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
20. Solin LJ, Fourquet A, McCormick B, et al. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys 1994;30:3-9.
21. Guidi AJ, Schnitt SJ, Fischer L, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 1997;80:1945-53.
22. Lee AHS, Dublin EA, Bobrow LG. Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast. J Pathol 1999;187:285-90.
23. Folkman J. What is the role of thymidine phosphorylase in tumour angiogenesis. J Natl Cancer Inst 1996;88:1091-2.
24. Nagaoka H, Iino Y, Takei H, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumour angiogenesis and prognosis in invasive breast cancer. Int J Oncol 1998;13:449-54.
25. Fox SB, Westwood M, Moghaddam A, et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is upregulated in breast cancer epithelium and endothelium. Br J Cancer 1996;73:275-80.
26. Toi M, Hoshina S, Taniguchi T, et al. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995;64:79-82.
27. Griffiths L, Dachs GU, Bicknell T, et al. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast rumour cells grown in vitro and in vivo. Cancer Res 1997;57:570-2.